2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis      E6CF781F3D07C386647CEFDED26B8578  A strong recommendation was made to use oral bisphosphonates (BPs) over no treatment for adults â‰¥40 years receiving long-term GCs, at high and very high risk for fracture, based on available fracture data in GIOP populations. Other agents including intravenous BPs, PTH/PTHrP, and denosumab (DEN) are also options and are conditionally